PubMed

• Rituximab (anti-CD20) selectively modifies Bcl-xL and apoptosis protease activat...
  Rituximab (anti-CD20) selectively modifies Bcl-xL and apoptosis protease activating factor-1 (Apaf-1) expression and sensitizes human non-Hodgkin's lymphoma B cell lines to paclitaxel-induced apoptosis.

  Mol Cancer Ther. 2003 Nov ;2(11):1183-93.
  PubMed
• Methylguanine methyltransferase-mediated in vivo selection and chemoprotection o...
  Methylguanine methyltransferase-mediated in vivo selection and chemoprotection of allogeneic stem cells in a large-animal model.

  J Clin Invest. 2003 Nov ;112(10):1581-8.
  PubMed
• Cyclic AMP response element binding protein CREB and modulator protein CREM are ...
  Cyclic AMP response element binding protein CREB and modulator protein CREM are products of distinct genes.

  Nucleic Acids Res. 1992 Nov 25 ;20(22):6106.
  PubMed
• Safety assessment of Salicylic Acid, Butyloctyl Salicylate, Calcium Salicylate, ...
  Safety assessment of Salicylic Acid, Butyloctyl Salicylate, Calcium Salicylate, C12-15 Alkyl Salicylate, Capryloyl Salicylic Acid, Hexyldodecyl Salicylate, Isocetyl Salicylate, Isodecyl Salicylate, Magnesium Salicylate, MEA-Salicylate, Ethylhexyl Salicylate, Potassium Salicylate, Methyl Salicylate, Myristyl Salicylate, Sodium Salicylate, TEA-Salicylate, and Tridecyl Salicylate.

  Int J Toxicol. 2003 ;22 Suppl 3:1-108.
  PubMed
• ABO exon and intron analysis in individuals with the AweakB phenotype reveals a ...
  ABO exon and intron analysis in individuals with the AweakB phenotype reveals a novel O1v-A2 hybrid allele that causes four missense mutations in the A transferase.

  BMC Genet. 2003 Nov 17 ;4:17.
  PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on